You have no items in your shopping cart.
RecombinantIHH,Human [orb1494835]> 95% as analyzed by SDS-PAGE.
20 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg- RecombinantIGF-II,Human [orb1494836]
> 95% as analyzed by SDS-PAGE and HPLC.
7.6 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg - RecombinantIGF-I,Rat [orb1494837]
> 95% as analyzed by SDS-PAGE and HPLC.
7.8 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg - RecombinantIGF-I,Mouse [orb1494838]
> 95% by SDS-PAGE analysis.
7.8 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg - RecombinantIGF-I,Human [orb1494839]
> 95% by SDS-PAGE and HPLC analyses.
7.7 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg - RecombinantIGF-I(N-Met),Human [orb1494840]
> 95% as analyzed by SDS-PAGE.
7.8 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
50 μg, 10 μg, 1 mg - RecombinantIFN-γ,Rat [orb1494841]
> 95% as analyzed by SDS-PAGE and HPLC.
15.5 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
1 mg, 50 μg, 10 μg - RecombinantIFN-γ,Mouse [orb1494842]
> 95% as analyzed by reducing SDS-PAGE.
15 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
1 mg, 100 μg, 20 μg - RecombinantIFN-γ,Human [orb1494843]
> 95% as analyzed by reducing SDS‐PAGE.
17kDa, observed by reducing SDS‐PAGE.
Escherichia coli.
100 μg, 50 μg, 10 μg - RecombinantIFN-α2b,Human [orb1494844]
> 95% by SDS-PAGE and HPLC analyses.
19.2kDa, observed by reducing SDS-PAGE.
Escherichia coli.
1 mg, 50 μg, 10 μg